โก Quick Summary
This article discusses the rapid advancements of artificial intelligence (AI) in gynecologic oncology, emphasizing the need for a cautionary approach in the Indian context. While the potential benefits are significant, the authors highlight the understated perils associated with this technology.
๐ Key Details
- ๐ Publication Year: 2025
- ๐ Authors: Kumari S, Chandra R, Tiwari A
- ๐ Journal: Semin Oncol
- ๐ DOI: 10.1016/j.seminoncol.2025.152456
๐ Key Takeaways
- โ ๏ธ Caution is advised regarding the rapid integration of AI in gynecologic oncology.
- ๐ AI has immense potential to improve diagnostic accuracy and treatment outcomes.
- ๐ง Ethical considerations must be addressed to ensure patient safety and data privacy.
- ๐ The Indian healthcare context presents unique challenges and opportunities for AI implementation.
- ๐ Continuous evaluation of AI technologies is essential to mitigate risks.
- ๐ค Collaboration among oncologists, data scientists, and ethicists is crucial for responsible AI use.
- ๐ Future research should focus on the long-term impacts of AI in oncology.

๐ Background
The integration of artificial intelligence into healthcare, particularly in oncology, is transforming the landscape of patient care. In gynecologic oncology, AI has the potential to enhance diagnostic capabilities and personalize treatment plans. However, the rapid pace of AI development raises important questions about its implications, especially in diverse healthcare settings like India.
๐๏ธ Study
The authors of this article provide a comprehensive overview of the current state of AI in gynecologic oncology, focusing on the Indian context. They emphasize the importance of a cautious approach, advocating for thorough assessments of AI technologies before widespread adoption. The study highlights both the promising advancements and the potential risks associated with AI in this specialized field.
๐ Results
The article outlines several key findings regarding the application of AI in gynecologic oncology. While AI tools can significantly improve diagnostic accuracy and treatment planning, the authors stress that ethical concerns and data privacy issues must be prioritized. The need for ongoing research and evaluation is underscored to ensure that AI technologies are safe and effective for patient care.
๐ Impact and Implications
The implications of this study are profound. As AI continues to evolve, its integration into gynecologic oncology could lead to better patient outcomes and more efficient healthcare delivery. However, the authors caution that without careful consideration of ethical and practical challenges, the risks may outweigh the benefits. This calls for a collaborative effort among stakeholders to navigate the complexities of AI in healthcare.
๐ฎ Conclusion
This article serves as a vital reminder of the dual-edged nature of artificial intelligence in gynecologic oncology. While the potential for improved patient care is significant, it is essential to approach AI with caution and responsibility. Continued dialogue and research are necessary to harness the benefits of AI while safeguarding patient welfare. The future of gynecologic oncology may very well depend on how we navigate this exciting yet challenging frontier.
๐ฌ Your comments
What are your thoughts on the integration of AI in gynecologic oncology? We invite you to share your insights and engage in a discussion! ๐ฌ Leave your comments below or connect with us on social media:
Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.
Abstract
Artificial intelligence (AI) is making remarkable strides in the field of oncology. The potential is humongous, but the perils are understated. From the perspective of gynecologic oncologists from India, we urge everyone to take a cautionary look at the rapid AI evolution in oncology.
Author: [‘Kumari S’, ‘Chandra R’, ‘Tiwari A’]
Journal: Semin Oncol
Citation: Kumari S, et al. Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context. Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context. 2025; 53:152456. doi: 10.1016/j.seminoncol.2025.152456